Fleur Pellerin

Fleur Pellerin currently serves as a board member at Synapse Medicine and FINN, and as chairperson of the Mission Committee at Crédit Mutuel Alliance Fédérale. Since September 2016, Fleur Pellerin has been the CEO of Korelya Capital, and holds board member positions at KLM, Devialet, and Ledger, along with a role as president of CANNESERIES since September 2017. Fleur Pellerin was also a member of the board at Schneider Electric until May 2022 and is a member of the advisory committee at Talan. Educational credentials include a degree from ENA - Ecole nationale d'administration, Sciences Po, ESSEC Business School, and a Doctor of Arts from Sookmyung Women's University.